CTOs on the Move

Sinaiko Healthcare Consulting

www.sinaikohc.com

 
Sinaiko Healthcare Consulting is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.sinaikohc.com
  • 1875 Century Park E Ste 2100
    Los Angeles, CA USA 90067
  • Phone: 310.551.5252

Executives

Name Title Contact Details

Similar Companies

West Hills Health and Rehabilitation Center

West Hills Health and Rehabilitation Center is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Best Doctors

Best Doctors is the trusted expert medical resource that helps people take control of their healthcare. By connecting members and their treating physicians with world- renowned experts to confirm the right diagnosis and the right treatment, Best Doctors has a dramatic impact on the quality and cost of healthcare. The company delivers comprehensive, patient-centric, expert advice, empowering members and their physicians with specific, pertinent, actionable information. Better than a traditional second opinion, Best Doctors delivers a comprehensive evaluation of a member’s medical condition — providing value to both its members and their treating physicians.

Boyds Pharmacy

Boyds Pharmacy is a Florence, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DGIMED Ortho

DGIMED Ortho is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.